Abstract
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1021/jm200135z
Article citations
Benzoxazole-derivatives enhance progranulin expression and reverse the aberrant lysosomal proteome caused by GRN haploinsufficiency.
Nat Commun, 15(1):6125, 20 Jul 2024
Cited by: 0 articles | PMID: 39033178 | PMCID: PMC11271458
Therapeutic approaches for Duchenne muscular dystrophy.
Nat Rev Drug Discov, 22(11):917-934, 31 Aug 2023
Cited by: 16 articles | PMID: 37652974
Review
Design, synthesis and characterization of lead compounds as anti-inflammatory drugs targeting mPGES-1 via enzymelink screening.
Future Med Chem, 15(9):757-767, 30 May 2023
Cited by: 0 articles | PMID: 37248701 | PMCID: PMC10318571
Heteroaromatic Diazirines Are Essential Building Blocks for Material and Medicinal Chemistry.
Molecules, 28(3):1408, 01 Feb 2023
Cited by: 1 article | PMID: 36771073 | PMCID: PMC9921084
Review Free full text in Europe PMC
Decreasing HepG2 Cytotoxicity by Lowering the Lipophilicity of Benzo[d]oxazolephosphinate Ester Utrophin Modulators.
ACS Med Chem Lett, 11(12):2421-2427, 04 Nov 2020
Cited by: 2 articles | PMID: 33335663 | PMCID: PMC7734801
Go to all (31) article citations
Data
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
2-Arylbenzo[d]oxazole Phosphinate Esters as Second-Generation Modulators of Utrophin for the Treatment of Duchenne Muscular Dystrophy.
J Med Chem, 63(14):7880-7891, 10 Jul 2020
Cited by: 6 articles | PMID: 32551645
Structure-activity relationships of 2-pyrimidinecarbohydrazides as utrophin modulators for the potential treatment of Duchenne muscular dystrophy.
Bioorg Med Chem, 69:116812, 18 May 2022
Cited by: 2 articles | PMID: 35772287
Chemical Proteomics and Phenotypic Profiling Identifies the Aryl Hydrocarbon Receptor as a Molecular Target of the Utrophin Modulator Ezutromid.
Angew Chem Int Ed Engl, 59(6):2420-2428, 03 Jan 2020
Cited by: 16 articles | PMID: 31755636 | PMCID: PMC7003794
Duchenne muscular dystrophy drug discovery - the application of utrophin promoter activation screening.
Expert Opin Drug Discov, 8(5):569-581, 09 Mar 2013
Cited by: 13 articles | PMID: 23473647
Review
Funding
Funders who supported this work.
Medical Research Council (1)
Molecular analysis of neuromuscular and neurological disease
Professor Dame Kay Davies, MRC Functional Genetics Unit
Grant ID: MC_U137761449